Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1999 2
2000 1
2001 2
2002 1
2003 3
2004 3
2006 7
2007 1
2008 1
2010 1
2011 2
2012 1
2013 2
2016 1
2017 2
2018 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Results by year

Filters applied: . Clear all
Page 1
RAZOR: A Phase II Open Randomized Trial of Screening Plus Goserelin and Raloxifene Versus Screening Alone in Premenopausal Women at Increased Risk of Breast Cancer.
Howell A, Ashcroft L, Fallowfield L, Eccles DM, Eeles RA, Ward A, Brentnall AR, Dowsett M, Cuzick JM, Greenhalgh R, Boggis C, Motion J, Sergeant JC, Adams J, Evans DG. Howell A, et al. Cancer Epidemiol Biomarkers Prev. 2018 Jan;27(1):58-66. doi: 10.1158/1055-9965.EPI-17-0158. Epub 2017 Nov 2. Cancer Epidemiol Biomarkers Prev. 2018. PMID: 29097444 Clinical Trial.
A randomized phase II presurgical trial of weekly low-dose tamoxifen versus raloxifene versus placebo in premenopausal women with estrogen receptor-positive breast cancer.
Serrano D, Lazzeroni M, Gandini S, Macis D, Johansson H, Gjerde J, Lien E, Feroce I, Pruneri G, Sandri M, Bassi F, Brenelli F, Luini A, Cazzaniga M, Varricchio C, Guerrieri-Gonzaga A, DeCensi A, Bonanni B. Serrano D, et al. Breast Cancer Res. 2013 Jun 20;15(3):R47. doi: 10.1186/bcr3439. Breast Cancer Res. 2013. PMID: 23786776 Free PMC article. Clinical Trial.
An evaluation of the Fracture Risk Assessment Tool (FRAX) as an indicator of treatment efficacy: the effects of bazedoxifene and raloxifene on vertebral, nonvertebral, and all clinical fractures as a function of baseline fracture risk assessed by FRAX.
Kaufman JM, Palacios S, Silverman S, Sutradhar S, Chines A. Kaufman JM, et al. Osteoporos Int. 2013 Oct;24(10):2561-9. doi: 10.1007/s00198-013-2341-6. Epub 2013 Apr 18. Osteoporos Int. 2013. PMID: 23595562 Clinical Trial.
Patient-reported symptoms and quality of life during treatment with tamoxifen or raloxifene for breast cancer prevention: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial.
Land SR, Wickerham DL, Costantino JP, Ritter MW, Vogel VG, Lee M, Pajon ER, Wade JL 3rd, Dakhil S, Lockhart JB Jr, Wolmark N, Ganz PA. Land SR, et al. JAMA. 2006 Jun 21;295(23):2742-51. doi: 10.1001/jama.295.23.joc60075. Epub 2006 Jun 5. JAMA. 2006. PMID: 16754728 Clinical Trial.
Gynecologic and hormonal effects of raloxifene in premenopausal women.
Premkumar A, Venzon DJ, Avila N, Johnson DV, Remaley AT, Forman MR, Eng-Wong J, Zujewski J, Stratton P. Premkumar A, et al. Fertil Steril. 2007 Dec;88(6):1637-44. doi: 10.1016/j.fertnstert.2007.01.095. Epub 2007 Jul 26. Fertil Steril. 2007. PMID: 17662283 Free article. Clinical Trial.
29 results